IRIS
PANTANO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.254
NA - Nord America 3.792
EU - Europa 1.355
SA - Sud America 443
Continente sconosciuto - Info sul continente non disponibili 137
AF - Africa 60
OC - Oceania 16
AN - Antartide 1
Totale 13.058
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 5.038
US - Stati Uniti d'America 3.625
CN - Cina 1.021
IT - Italia 677
HK - Hong Kong 588
BR - Brasile 288
FR - Francia 179
VN - Vietnam 161
GB - Regno Unito 146
BD - Bangladesh 144
DE - Germania 94
IN - India 80
CA - Canada 74
NL - Olanda 56
AR - Argentina 51
MX - Messico 48
ID - Indonesia 39
CO - Colombia 37
TR - Turchia 28
JP - Giappone 26
FI - Finlandia 25
RU - Federazione Russa 24
CZ - Repubblica Ceca 20
EC - Ecuador 18
SA - Arabia Saudita 18
ES - Italia 17
PL - Polonia 16
UA - Ucraina 16
ZA - Sudafrica 16
AU - Australia 15
VE - Venezuela 15
PH - Filippine 13
CR - Costa Rica 12
MY - Malesia 12
SE - Svezia 12
AT - Austria 11
JM - Giamaica 11
PK - Pakistan 10
PY - Paraguay 10
EE - Estonia 9
IQ - Iraq 9
UZ - Uzbekistan 9
CL - Cile 8
KR - Corea 8
PE - Perù 8
TN - Tunisia 8
BH - Bahrain 7
MA - Marocco 7
MD - Moldavia 7
DZ - Algeria 6
LT - Lituania 6
NP - Nepal 6
BO - Bolivia 5
EG - Egitto 5
JO - Giordania 5
KZ - Kazakistan 5
PT - Portogallo 5
RO - Romania 5
RS - Serbia 5
TT - Trinidad e Tobago 5
BE - Belgio 4
GR - Grecia 4
KE - Kenya 4
AZ - Azerbaigian 3
BY - Bielorussia 3
DK - Danimarca 3
HN - Honduras 3
NI - Nicaragua 3
CH - Svizzera 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
KG - Kirghizistan 2
KW - Kuwait 2
LV - Lettonia 2
LY - Libia 2
MN - Mongolia 2
PS - Palestinian Territory 2
QA - Qatar 2
SN - Senegal 2
TH - Thailandia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
GH - Ghana 1
GP - Guadalupe 1
GT - Guatemala 1
GY - Guiana 1
HT - Haiti 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
Totale 12.901
Salva come PNG Salva come JPEG
Città #
San Jose 993
Ashburn 678
Singapore 670
Hong Kong 587
Rome 440
Hefei 331
Beijing 283
Dallas 238
Council Bluffs 220
Boardman 174
Columbus 174
Lauterbourg 149
London 117
Shanghai 114
Santa Clara 92
Los Angeles 72
New York 54
Ho Chi Minh City 52
Phoenix 48
San Francisco 41
Munich 40
Hanoi 37
São Paulo 34
Amsterdam 31
Mexico City 27
Brooklyn 25
Pune 25
Toronto 24
Orem 22
Brno 19
Chicago 19
Montreal 18
Seattle 18
Las Vegas 16
Redmond 16
Milan 15
Washington 15
Helsinki 14
Tokyo 14
Warsaw 12
Frankfurt am Main 11
San José 11
Buffalo 10
Chennai 10
Haiphong 10
Stockholm 10
Turku 10
Ankara 9
Atlanta 9
Hyderabad 9
Naples 9
Riyadh 9
Tashkent 9
Xi'an 9
Bogotá 8
Boston 8
Denver 8
Melbourne 8
Biên Hòa 7
Charlotte 7
Johannesburg 7
Manchester 7
Philadelphia 7
Quito 7
Ribeirão Preto 7
Bologna 6
Canberra 6
Curitiba 6
Guayaquil 6
Hangzhou 6
Kingston 6
Miami 6
Moscow 6
Paris 6
Rio de Janeiro 6
Asunción 5
Belo Horizonte 5
Buenos Aires 5
Campinas 5
Hamad Town 5
Jakarta 5
Louisville 5
Medellín 5
Mumbai 5
New Delhi 5
Porto Alegre 5
The Dalles 5
Yeonsu-gu 5
Athens 4
Bauru 4
Capaccio 4
Caracas 4
Chaguanas 4
Cincinnati 4
Da Nang 4
Dhaka 4
Durham 4
Genoa 4
Ha Long 4
Houston 4
Totale 6.357
Salva come PNG Salva come JPEG
Nome #
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 307
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? 267
Expression pattern of receptor activator of NFκB (RANK) in a series of primary solid tumors and related bone metastases 260
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 251
Artificial Intelligence in Detection, Management, and Prognosis of Bone Metastasis: A Systematic Review 247
Abstract 486: MicroRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes 240
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 239
Designing a broad-spectrum integrative approach for cancer prevention and treatment 239
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 237
Premetastatic niche: ready for new therapeutic interventions? 223
NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population 202
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 198
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 171
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 161
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 160
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 152
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies 150
Clinical outcomes among major breast cancer subtypes after neoadjuvant chemotherapy: Impact on breast cancer recurrence and survival 137
Subaxillary Replacement Flap Compared with the Round Block Displacement Technique in Oncoplastic Breast Conserving Surgery: Functional Outcomes of a Feasible One Stage Reconstruction 137
Serum VEGF levels as predictive marker of bisphosphonate-related osteonecrosis of the jaw 136
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 136
Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis 135
Anterior and posterior vaginal myomectomy: A new surgical technique 132
A novel germline mutation at exon 10 of MEN1 gene: a clinical survey and positive genotype-phenotype analysis of a MEN1 Italian family, including monozygotic twins 132
Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. 130
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 130
Biological effects of cabozantinib on bone microenvironment 129
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells. 128
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 127
Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions 127
Preoperative Ultrasound-guided Sub-areolar Biopsy in Predicting Occult Nipple Involvement in Breast Cancer Patients: Proposal for a Methodological Approach 124
Heterogeneous risk profiles among B3 breast lesions of uncertain malignant potential 123
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 123
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 122
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 119
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 119
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 117
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer 110
A Nanostring gene expression approach identifies aggressive clinical behavior related genes in dedifferentiated liposarcoma 104
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients 96
Fragile X mental retardation protein in intrahepatic cholangiocarcinoma: regulating the cancer cell behavior plasticity at the leading edge 93
Role of c-mesenchymal-epithelial transition pathway in gastric cancer 90
S-p-bromobenzyl-glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical models 87
Molecular prognostic factors in patients with pancreatic cancer 80
MicroRNAs and bone metastasis: a new challenge 80
Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7) 71
Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis 69
New targets, new drugs for metastatic bone pain: a new philosophy 69
CETUXIMAB: From bench to bedside 68
MUC2 but not MUC5 expression correlates with prognosis in radically resected pancreatic cancer patients 66
Osteoblasts Promote Prostate Cancer Cell Proliferation Through Androgen Receptor Independent Mechanisms 66
Breast CancerTrastuzumab-deruxtecan and radiotherapy: a safety sub-analysis of combart prospective cohort study 65
Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part II: Treatment 65
Denosumab for cancer-related bone loss 64
Corrigendum: Natural History of Non-Small-Cell Lung Cancer with Bone Metastases 63
miRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis–associated genes 63
The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients 61
The role of bone microenvironment, vitamin D and calcium 61
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma 60
Protective effects of miR-24-2-5p in early stages of breast cancer bone metastasis 59
Classification of M1/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysis 59
The Synergistic Effect of Everolimus and Chloroquine on Endothelial Cell Number Reduction Is Paralleled by Increased Apoptosis and Reduced Autophagy Occurrence 59
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan A Phase 2 Single-Arm Clinical Trial 59
Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients 59
The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials 59
Osteoblast Secretome Modulated by Abiraterone Treatment Affects Castration Resistant Prostate Cancer Cell Proliferation 59
Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab 58
Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone 58
Interleukin 1ss-511T gene (IL1ss) polymorphism is correlated with gastric cancer in the Caucasian population: Results from a meta-analysis 57
Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer 57
Olaratumab: PDGFR-alpha inhibition as a novel tool in the treatment of advanced soft tissue sarcomas 57
Predictive factors of response to treatment in patients with metastatic renal cell carcinoma: new evidence 57
Breakthrough Cancer Pain Clinical Features and Differential Opioids Response: A Machine Learning Approach in Patients With Cancer From the IOPS-MS Study 57
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives 57
Prognostic and predictive factors in pancreatic cancer 56
Clinical outcomes of metastatic renal carcinoma following disease progression to programmed death (PD)-1 or PD-L1 inhibitors (I-O): A Meet-URO group real-world study (Meet-Uro 7) 56
The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: a new pharmacodynamic marker? 54
Neutrophil-to-lymphocyte ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and outcomes with nivolumab in pretreated Non-Small Cell Lung Cancer (NSCLC): a large retrospective multicenter study 54
New Technologies to Study the Interplay between Cancer Stem Cells and the Immune System 53
Epidemiologia e caratteristiche delle metastasi ossee 53
Regression of papillary thyroid cancer during nivolumab for renal cell cancer 53
Network approach in liquidomics landscape 53
Cabozantinib affects osteosarcoma growth through a direct effect on tumor cells and modifications in bone microenvironment 52
Targeting bone metastases starting from the preneoplastic niche: home sweet home 52
Tissue invasion and metastasis: Molecular, biological and clinical perspectives. 52
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation 52
Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: A systematic review and meta-analysis of clinical trials 52
Clinical performance of implanted devices used in surgical treatment of patients with spinal tumors: a systematic review 52
Circulating receptor activator of nuclear factor kappa-B ligand (RANKL) levels predict response to immune checkpoint inhibitors in advanced non-small cell lung cancer (NSCLC) 51
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients 51
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 51
Deregulation of dicer and mir-155 expression in liposarcoma 51
The Role of the CDK4/6 Inhibitor Ribociclib in Locally Advanced and Oligometastatic Hormone Receptor Positive, Her2 Negative, Advanced Breast Cancer: Case Series and Review of the Literature 50
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases 50
Interventional radiologist's perspective on the management of bone metastatic disease 50
COVID-19 pneumonia and immune-related pneumonitis: critical issues on differential diagnosis, potential interactions, and management 50
New developments of aminobisphosphonates: the double face of Janus 50
Natural History of Malignant Bone Disease in Gastric Cancer: Final Results of a Multicenter Bone Metastasis Survey 50
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs) 50
Effects of cabozantinib on bone turnover markers in real-world metastatic renal cell carcinoma 50
Totale 10.137
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.356
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.356
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022328 0 0 9 1 89 4 8 1 12 1 3 200
2022/202363 2 1 0 1 4 3 7 15 1 3 23 3
2023/2024508 16 49 30 31 50 224 6 20 6 24 16 36
2024/20255.748 76 92 206 49 39 137 115 31 491 456 1.794 2.262
2025/20265.527 484 226 397 511 249 349 1.457 401 454 539 273 187
2026/2027884 121 552 211 0 0 0 0 0 0 0 0 0
Totale 13.058